Abiopharma

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Baker Hughes Announces Dates for Second-Quarter Earnings Release and Webcast

Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

Fury Announces Results of Annual General Meeting of Shareholders

Mandatory Cash Dividend/ Distribution:

General Announcement: Net Asset Value Per Unit

DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

Net Asset Value(s)

BOSS Zhipins Ongoing Share Repurchases Reach Over RMB1.99 Billion in 2026